Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

JDRF

Novo Nordisk invests $100m in research in China

Expands existing site in Beijing

Novartis building

CHMP backs trio of Novartis products

Including two diabetes drugs and one for non-cancerous kidney tumours

- PMLiVE

Sanofi signs tuberculosis research deal with TB Alliance

Aims to shorten regimens and tackle drug-resistant forms of infection

Diabetes apps present usability problems for older adults

Researchers find a range of potential design problems with smartphone apps

- PMLiVE

Boehringer-Lilly tap into behavioural change for online diabetes programme

Part of the partners' Tradjenta marketing, My Well Planner offers personalised educational resources

- PMLiVE

Sanofi to announce up to 2,500 job cuts next week says paper

Le Figaro claims losses will mainly affect France

- PMLiVE

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

- PMLiVE

Sanofi taps Oncodesign for kinase inhibitor platform

French firms form €130m alliance

- PMLiVE

Interview: Cavan Redmond, WebMD

The new CEO of WebMD talks to PMLiVE about his move from Pfizer

- PMLiVE

FDA clears Sanofi’s oral MS drug Aubagio

Will compete with Novartis’ Gilenya

- PMLiVE

Sanofi’s dengue vaccine shows signs of efficacy

Pharma company shows off encouraging phase IIb data, but some questions remain

Grey Healthcare Group introduces brand influence tracker

Programme helps assess the impact of healthcare companies online

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links